NihBiotechGrantPulse / compare

VAST THERAPEUTICS, INC. vs OPUS GENETICS INC.: NihBiotechGrantPulse comparison

OPUS GENETICS INC.'s award of $1,004,925 is 1.0x VAST THERAPEUTICS, INC.'s $1,000,000 (87th percentile). VAST THERAPEUTICS, INC. is dated 2026-09-14; OPUS GENETICS INC. 2026-09-19.

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

Both records plus every comparable NC record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does VAST THERAPEUTICS, INC. compare to OPUS GENETICS INC.?

FieldVAST THERAPEUTICS, INC.OPUS GENETICS INC.
OrganizationVAST THERAPEUTICS, INC.OPUS GENETICS INC.
LocationMorrisville, NCRALEIGH, NC
ProjectInhaled Nitric-Oxide Releasing Prodrug to Treat Drug Resistant Klebsiella pneumoniae InfectionsDevelopment of OPGx-RDH12 as a gene therapy for RDH12 deficiency associated Leber congenital amaurosis (LCA)
Project number1R44AI191890-01A11R44EY038152-01A1
MechanismR44R44
InstituteNational Institute of Allergy and Infectious DiseasesNational Eye Institute
Award$1,000,000$1,004,925
Awarded2026-09-142026-09-19
Project period2026-09-14 to 2028-08-312026-09-30 to 2028-06-30
UEICYDMYQAP1ZW7YD2GB4S983V9
award percentile87th87th
Lab Budget Score70/10070/100
Peer rank and all 454 NC records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: VAST THERAPEUTICS, INC. · OPUS GENETICS INC.

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together